Movicol /01625101/


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 88.9%
Staphylococcal Sepsis 11.1%
Tendonitis 100.0%
Concomitant
Product Used For Unknown Indication 55.9%
Drug Use For Unknown Indication 8.9%
Sarcoma Metastatic 5.7%
Pain 5.0%
Prophylaxis 3.3%
Constipation 3.2%
Diffuse Large B-cell Lymphoma 2.5%
Hypertension 2.2%
Osteoporosis 2.0%
Rhabdomyosarcoma 1.9%
Sarcoma 1.9%
Non-small Cell Lung Cancer 1.1%
Chemotherapy 0.9%
Asthma 0.8%
Colon Cancer 0.8%
Depression 0.8%
Gastrooesophageal Reflux Disease 0.8%
Cardiovascular Disorder 0.7%
Nausea 0.7%
Urinary Tract Infection 0.7%
Mucosal Inflammation 10.0%
Bradycardia 6.7%
Death 6.7%
Febrile Neutropenia 6.7%
Nausea 6.7%
Vomiting 6.7%
Weight Increased 6.7%
Inappropriate Schedule Of Drug Administration 5.0%
Ingrowing Nail 5.0%
Neutropenia 5.0%
Pulmonary Embolism 5.0%
Angioedema 3.3%
Atrial Fibrillation 3.3%
Bone Pain 3.3%
Delirium 3.3%
Epistaxis 3.3%
Fatigue 3.3%
General Physical Health Deterioration 3.3%
Grand Mal Convulsion 3.3%
Hypotension 3.3%
Interacting
Constipation 66.7%
Schizophrenia 16.7%
Tremor 16.7%
Tremor 100.0%

Drug Data